Technology: Cell-based gene therapy
Industry: Gene therapy, Private
Headquarters: Cambridge, Massachusetts, United States
Founded Date: 2015-01-01
Employees Number: 51-100
Funding Status: Early Stage Venture
Investors Number: 18
Total Funding: 164500000
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-09-09
Last Funding Type: Series B

Visit Website
info@obsidiantx.com
https://twitter.com/obsidian_tx
Register and Claim Ownership